Image of a procoagulant and anticoagulant

Image of a procoagulant and anticoagulant

Home > Resources

style
Bread-crumb

Resources

Access Pfizer and third-party resources for people with hemophilia A or B, caregivers, and families.

Downloadable PDF

Rebalancing Hemophilia Brochure

Printable brochure on rebalancing.

Website

Together For Rare

Real support from real representatives.

Downloadable app

HemMobile App

HemMobile® is designed to help hemophilia patients/caregivers log infusions of any factor replacement product, record bleeds, and track activity.

Website

The World Federation of Hemophilia Shared Decision-making Tool

Shared decision-making (SDM) is a process where you and your healthcare team work together to make a decision about your hemophilia care and treatment.

Rebalancing therapy is not approved for use in hemophilia in the United States.

This resource is published by the World Federation of Hemophilia (WFH) and has been linked here with permission.

© 2023 World Federation of Hemophilia https://sdm.wfh.org/

Video

Rebalancing is a team effort

Watch how hemostasis works.

Video_id
6350575904112
Account_id
1852113022001
poster
Rebalancing is a team Effort.
style
Sign-up-more-block

Pfizer has been committed to innovations in hemophilia for more than 25 years.

Pfizer has been committed to innovations in hemophilia for more than 25 years.

Pfizer Outdo Yesterday logo

Pfizer has been committed to innovations in hemophilia care for more than 25 years.

Pfizer has a long history of supporting the hemophilia community, and we remain committed to innovation and continued research. While significant progress has been made, we believe more can be done to improve treatment.

Pfizer is currently working to unlock the potential of rebalancing for people living with hemophilia worldwide.